Free Trial

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$3.72 -0.07 (-1.85%)
As of 07/1/2025 04:00 PM Eastern

AVR vs. AVNS, BVS, EMBC, RXST, KIDS, DCTH, BFLY, AXGN, SMLR, and TMCI

Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include AVANOS MEDICAL (AVNS), Bioventus (BVS), Embecta (EMBC), RxSight (RXST), OrthoPediatrics (KIDS), Delcath Systems (DCTH), Butterfly Network (BFLY), AxoGen (AXGN), Semler Scientific (SMLR), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

Anteris Technologies Global vs. Its Competitors

Anteris Technologies Global (NASDAQ:AVR) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Anteris Technologies Global currently has a consensus target price of $16.50, indicating a potential upside of 343.55%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, equities research analysts plainly believe Anteris Technologies Global is more favorable than Avanos Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Avanos Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Anteris Technologies Global has higher earnings, but lower revenue than Avanos Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anteris Technologies Global$2.70M49.68-$76.29MN/AN/A
Avanos Medical$687.80M0.84-$392.10M-$8.37-1.49

In the previous week, Anteris Technologies Global and Anteris Technologies Global both had 1 articles in the media. Anteris Technologies Global's average media sentiment score of 1.89 beat Avanos Medical's score of 1.84 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company Overall Sentiment
Anteris Technologies Global Very Positive
Avanos Medical Very Positive

95.2% of Avanos Medical shares are held by institutional investors. 2.6% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Anteris Technologies Global has a net margin of 0.00% compared to Avanos Medical's net margin of -55.80%. Avanos Medical's return on equity of 6.26% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Anteris Technologies GlobalN/A N/A N/A
Avanos Medical -55.80%6.26%4.63%

Summary

Anteris Technologies Global beats Avanos Medical on 7 of the 12 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

MetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$136.68M$6.78B$5.48B$8.94B
Dividend YieldN/A1.04%5.38%4.12%
P/E RatioN/A27.0626.2119.74
Price / Sales49.6885.89395.44109.12
Price / CashN/A21.0536.4957.06
Price / Book2.144.707.935.37
Net Income-$76.29M$173.18M$3.15B$248.34M
7 Day Performance-6.06%0.20%0.75%1.67%
1 Month Performance-19.65%-1.11%3.45%4.56%
1 Year PerformanceN/A24.36%34.85%18.42%

Anteris Technologies Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
N/A$3.72
-1.8%
$16.50
+343.5%
N/A$136.68M$2.70M0.00138Gap Up
AVNS
AVANOS MEDICAL
2.3924 of 5 stars
$12.20
+0.2%
N/A-36.6%$563.43M$687.80M-1.462,227
BVS
Bioventus
3.382 of 5 stars
$6.73
+1.0%
$14.33
+113.1%
+21.6%$552.42M$567.70M-11.021,200Positive News
EMBC
Embecta
4.4538 of 5 stars
$9.41
+1.4%
$19.33
+105.5%
-15.6%$550.51M$1.12B10.472,100
RXST
RxSight
2.6621 of 5 stars
$12.98
-1.9%
$37.90
+192.1%
-76.9%$526.21M$139.93M-19.33220Positive News
KIDS
OrthoPediatrics
4.2469 of 5 stars
$21.55
-1.0%
$35.83
+66.3%
-22.5%$523.45M$204.73M-12.31200
DCTH
Delcath Systems
3.3324 of 5 stars
$14.05
flat
$24.00
+70.8%
+54.5%$489.88M$37.21M-28.1360
BFLY
Butterfly Network
2.2512 of 5 stars
$1.95
-3.7%
$4.00
+105.7%
+118.5%$483.45M$82.06M-6.74460News Coverage
Analyst Forecast
AXGN
AxoGen
2.6831 of 5 stars
$10.33
-1.4%
$22.20
+115.0%
+42.2%$466.56M$187.34M-68.30450Positive News
SMLR
Semler Scientific
2.3021 of 5 stars
$39.36
+1.5%
$71.00
+80.4%
+5.0%$438.81M$56.29M-15.08120
TMCI
Treace Medical Concepts
2.4716 of 5 stars
$5.65
+1.1%
$10.16
+79.8%
-7.2%$355.20M$209.36M-6.64250Positive News

Related Companies and Tools


This page (NASDAQ:AVR) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners